Cholangiocarcinoma, gallbladder, and bile duct cancers represent a family of diseases that occur in the liver, gallbladder, and bile ducts and share many common features as well as a common way of spreading. Cholangiocarcinoma, Gallbladder, and Bile Duct Cancers Treatment and surgery are planned according to the tumor location and how advanced the disease is. An extremely thorough workup looking for distant spread is mandatory before any surgery is attempted. Unlike colorectal and ovarian cancers, surgery for these tumors has not shown significant benefit if the cancer has spread to a distant site.

Patients and medical professionals from America and around the world seek out his specialized best in class individualized treatments and services including his expert surgical management of the patient’s condition.

Patients referred to Dr. Alden have access to a vast array of specialists who are some of the best in their field in the country (and possibly in the world).

Please note: Dr. Alden accepts insurance if he participates with your plan. Additionally, if Dr. Alden does not participate with your insurance plan, Dr. Alden’s office is frequently able to obtain pre-authorization from your insurance plan based on the uniqueness of his specialty. We will contact your insurance company to understand your benefits and additionally submit them for you. You will enjoy the luxury and benefit of academic medicine in a top rated concierge environment without the hassle of long hospital waiting room times and paperwork. Most policies reimburse patients for most of the cost of surgery. Our surgical coordinator will help you with a quote.

Our best in class staff regularly performs individualized Cholangiocarcinoma, Gallbladder, and Bile Duct Cancers Surgery on patients with these cancers and have acquired more than a decade of operating experience in this field.

Highly recommended , extremely professional with excellent bedside manners, great surgeon , top doctor. Works with best doctors team. Saving people life. ~ Google

For example, the image to the left represents Right Intra-Hepatic Cholangiocarcinoma invading the Right Portal Vein and causing atrophy of the Right Lobe of the Liver and hypertrophy of the Left and Caudate Lobes.

From a technical standpoint, cholangiocarcinoma, gallbladder, and bile duct cancer tumors represent possibly the most challenging oncological surgery cases. Although they rarely grow large, these tumors are commonly invading or are in direct contact with the liver’s most vital structures. The oncological surgery, therefore, requires a high level of skill, technical expertise, and in-depth knowledge of the liver anatomy as well as all its multiple variations that are so common.

The entire bile duct is almost always removed during the surgery, and a highly complex reconstruction is required to connect any remaining bile duct (often multiple small ones) to a specially constructed loop of the intestine (Roux-en-Y anastomosis). In some cases, it is necessary to remove a portion or an entire lobe of the liver. The most advanced tumors would demand removal and reconstruction of blood vessels (most commonly the portal vein and/or hepatic artery).

The quality of the resection achieving “negative margins” (leaving no cancer behind) is the most important prognostic factor for future survival. In summary, Cholangiocarcinoma and Bile Duct Cancer Surgeries are of extremely high complexity and leave very little room for error.

In addition to an office-based consultation, the NYC liver cancer & pancreatic cancer surgeon offers remote consultations to patients and medical professionals anywhere in the world. Please call our office for details.

For more information on Cholangiocarcinoma, Gallbladder, and Bile Duct Cancers surgeries or to schedule a consultation with the Cholangiocarcinoma, Gallbladder, and Bile Duct Cancers Surgeon, please feel free to contact the NYC Liver, Pancreatic & Bile Duct Oncological Surgeon, Dmitri Alden, MD, FACS, today by phoning his New York office (212) 434-6216 or contacting us online.